B. Laat

发表

Whole blood thrombin generation profiles of patients with cirrhosis explored with a near patient assay

V. Patel, M. Roest, W. Bernal, 2020, Journal of thrombosis and haemostasis : JTH.

Comparing thrombin generation in patients with hemophilia A and patients on vitamin K antagonists

A. Huisman, R. Schutgens, M. Ninivaggi, 2017, Journal of thrombosis and haemostasis : JTH.

Mechanisms of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome.

P. Groot, B. Laat, 2017 .

Clinical and Prognostic Significance of Non-criteria Antiphospholipid Antibody Tests

A. Tincani, R. Kumar, P. Meroni, 2017 .

Mechanisms of Disease: antiphospholipid antibodies—from clinical association to pathologic mechanism

K. Mertens, P. Groot, B. Laat, 2008, Nature Clinical Practice Rheumatology.

Natural Proteins Involved in Antiphospholipid Syndrome

J. Rand, P. Vlachoyiannopoulos, P. Groot, 2017 .

Pathogenic anti- β 2 -glycoprotein I antibodies recognize domain I of β 2 -glycoprotein I only after a conformational change

R. Derksen, P. Groot, M. Pennings, 2005 .

' Non-criteria ' aPL tests : report of a task force and preconference workshop at the 13 th International

M. Petri, T. Atsumi, M. Lambert, 2011 .

‘Non-criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010

M. Petri, T. Atsumi, M. Lambert, 2011, Lupus.

Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I

J. Rand, Xiao-Xuan Wu, L. Schanberg, 2013, Lupus.

2-glycoprotein I only after a conformational change β 2-glycoprotein I antibodies recognize domain I of β Pathogenic anti-

R. Derksen, P. Groot, M. Pennings, 2011 .

In situ monitoring and optimization of CuAAC-mediated protein functionalization of biosurfaces

P. Adriaensens, W. Hermens, T. Vranken, 2017 .

Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH

T. Ortel, T. Atsumi, A. Tripodi, 2014, Journal of thrombosis and haemostasis : JTH.

Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH

W. Ageno, B. Cosmi, M. Crowther, 2016, Journal of thrombosis and haemostasis : JTH.

Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I

P. Groot, B. Laat, 2011 .

The (non‐)sense of detecting anti‐cardiolipin and anti‐β2glycoprotein I IgM antibodies in the antiphospholipid syndrome

J. Gris, P. D. de Groot, J. Musial, 2020, Journal of thrombosis and haemostasis : JTH.

SPECIAL ARTICLE Antibodies against domain I of b2-glycoprotein I: the one and only?

L. Pelkmans, B. Laat, 2012 .

Antibodies in APS with competing interest.

B. Laat, 2014 .

A5 2-glycoprotein I and a reduction in the anticoagulant activity of annexin β Correlation between antiphospholipid antibodies that recognize domain I of

Xiao-Xuan Wu, P. Groot, B. Laat, 2013 .

thrombosis 2-glycoprotein I cause LAC and their presence correlates strongly with β IgG antibodies that recognize epitope Gly40-Arg43 in domain I of

R. Derksen, R. Urbanus, P. Groot, 2013 .

Hyperresponsive Platelets and a Reduced Platelet Granule Release Capacity Are Associated with Severity and Mortality in COVID-19 Patients

Q. de Mast, A. J. van der Ven, M. Roest, 2022, Thrombosis and Haemostasis.

Task Force Report on “Non-criteria” Antiphospholipid Antibody Tests

M. Petri, J. Rand, T. Atsumi, 2012 .

Indications for a protective function of beta2‐glycoprotein I in thrombotic thrombocytopenic purpura

J. K. Kremer Hovinga, Z. Ruggeri, R. Fijnheer, 2012, British journal of haematology.

Rapid activation of endothelial cells enables P . falciparum adhesion to platelet decorated von Willebrand factor strings

A. Craig, M. Molyneux, G. Grau, 2010 .

adhesion and aggregation dependent platelet - 2-Glycoprotein I inhibits von Willebrand factor β

P. Lenting, R. Derksen, R. Fijnheer, 2013 .

Mixing studies in lupus anticoagulant testing are required at least in some type of samples

K. Devreese, B. Laat, 2015, Journal of thrombosis and haemostasis : JTH.

In vitro assessment, using thrombin generation, of the applicability of prothrombin complex concentrate as an antidote for Rivaroxaban

M. Ninivaggi, A. Leyte, H. Brinkman, 2013, Journal of thrombosis and haemostasis : JTH.

The Significance of Antibodies against Domain I of Beta-2 Glycoprotein I in Antiphospholipid Syndrome

W. Chayoua, B. de Laat, H. Kelchtermans, 2017, Seminars in Thrombosis and Hemostasis.

Differences in sensitivity of two automated assay panels for anticardiolipin and anti beta2glycoprotein I antibodies in the laboratory diagnosis of antiphospholipid syndrome due to the exposure of the domain I epitope of beta2glycoprotein I on the solid phase

K. Devreese, H. Kelchtermans, B. Laat, 2014 .

Binding of Erythrocyte ICAM–4 to the Platelet Activated Integrin α IIb β 3 leads to a Direct Erythrocyte-Platelet Adhesion Under Venous Flow Shear Rate

Z. Ruggeri, R. Wijk, P. Groot, 2012 .

β2-Glycoprotein I inhibits von Willebrand factor-dependent platelet adhesion and aggregation. Commentary

P. Lenting, R. Montgomery, R. Derksen, 2007 .

Scripts for the future. Technology foresight, strategic evaluation and sociothechnical networks: the confrontation of script based scenarios

B. de Laat, B. Laat, 1996 .

An international multicentre‐laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti‐beta2‐glycoprotein autoantibodies

P. D. de Groot, S. Čučnik, B. Božič, 2011, Journal of thrombosis and haemostasis : JTH.

IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis

K. Devreese, H. Kelchtermans, L. Pelkmans, 2016, Journal of thrombosis and haemostasis : JTH.

The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study

P. D. de Groot, T. Kveder, J. Rand, 2009, Journal of thrombosis and haemostasis : JTH.

Patient‐derived monoclonal antibodies directed towards beta2 glycoprotein‐1 display lupus anticoagulant activity

P. D. de Groot, J. Voorberg, R. Derksen, 2011, Journal of thrombosis and haemostasis : JTH.

Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH

T. Ortel, V. Pengo, K. Devreese, 2018, Journal of thrombosis and haemostasis : JTH.

Requirements for VWF mediated targeting of IGFBP 7 to Weibel-Palade bodies

J. Voorberg, B. S. Dragt, A. Meijer, 2013 .

Active von Willebrand Factor in patients with a bleeding diathesis

P. D. Kesel, M. Roest, D. Huskens, 2020 .

Commentary on: Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation

B. Laat, Dongmei Yin, 2019, Journal of thrombosis and haemostasis : JTH.

High prevalence of reduced thrombin generation and/or decreased platelet response in women with unexplained heavy menstrual bleeding

R. Urbanus, M. Roest, D. Huskens, 2018, International journal of laboratory hematology.

Identification of high thrombotic risk triple‐positive antiphospholipid syndrome patients is dependent on anti‐cardiolipin and anti‐β2glycoprotein I antibody detection assays

J. Musial, G. Moore, K. Devreese, 2018, Journal of thrombosis and haemostasis : JTH.

Annexin A5 polymorphism (−1C→T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome

P. D. de Groot, R. Derksen, W. V. van Heerde, 2006, Annals of the rheumatic diseases.